Literature DB >> 18361460

Compliance in cystic fibrosis: an examination of infection control guidelines.

Tracy Masterson1, Beth G Wildman, Benjamin Newberry, Gregory Omlor, Elizabeth Bryson, Ann Kukay.   

Abstract

The goal of this research was to begin the process of evaluating acceptability of infection control (IC) recommendations to CF patients and their families, determine whether compliance with IC guidelines differs from compliance with traditional CF medical treatment with respect to the variables predictive of compliance, and assess which patients are most likely to comply with IC recommendations. Participants were recruited during routine outpatient visits at a regional CF center located in a pediatric hospital. The sample included 44 child and adolescent patients, aged 9-18 years and their guardian, and 27 adult patients. All patients completed questionnaires and interviews. Results of this preliminary study suggest that many individuals with CF are unaware of or unconcerned with the risks involved in infection transmission via social contact with other CF patients. Further, most participants reported that they could benefit from friendships with other CF patients. Health belief variables were found to be predictive of compliance with both IC guidelines and traditional medical treatments in the adult and parent sample, but not in the child sample. Possible explanations for study findings are discussed and recommendations for future research on IC compliance are highlighted. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18361460     DOI: 10.1002/ppul.20781

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  2 in total

1.  User Preferences and Design Recommendations for an mHealth App to Promote Cystic Fibrosis Self-Management.

Authors:  Marisa E Hilliard; Amy Hahn; Alana K Ridge; Michelle N Eakin; Kristin A Riekert
Journal:  JMIR Mhealth Uhealth       Date:  2014-10-24       Impact factor: 4.773

Review 2.  Pro con debates in clinical medicine infection prevention and control in cystic fibrosis: One size fits all? The argument in favour.

Authors:  S Haggie; D A Fitzgerald
Journal:  Paediatr Respir Rev       Date:  2020-06-16       Impact factor: 2.726

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.